Select Publications

Journal articles

Clark PJ; Valery PC; Strasser SI; Weltman M; Thompson AJ; Levy M; Leggett B; Zekry A; Rong J; Angus P; George J; Bollipo S; McGarity B; Sievert W; Macquillan G; Tse E; Nicoll A; Wade A; Chu G; Harding D; Cheng W; Farrell G; Roberts SK, 2022, 'Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort.', Dig Dis Sci, http://dx.doi.org/10.1007/s10620-022-07483-y

Hall SAL; Burns GS; Anagnostou D; Vogrin S; Sundararajan V; Ratnam D; Levy MT; Lubel JS; Nicoll A; Strasser SI; Sievert W; Desmond PV; Ngu MC; Angus P; Sinclair M; Meredith C; Matthews G; Revill PA; Jackson K; Littlejohn M; Bowden D; Locarnini SA; Visvanathan K; Thompson A, 2022, 'Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels', Alimentary Pharmacology and Therapeutics, http://dx.doi.org/10.1111/apt.16968

Lockart I; Hajarizadeh B; Buckley N; Davison S; Prakoso E; Levy MT; George J; Dore GJ; Danta M, 2021, 'All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy', Journal of Gastroenterology and Hepatology (Australia), vol. 36, pp. 3515 - 3523, http://dx.doi.org/10.1111/jgh.15687

Papaluca T; Roberts SK; Strasser SI; Stuart KA; Farrell G; Macquillan G; Dore GJ; Wade AJ; George J; Hazeldine S; O'Beirne J; Wigg A; Fisher L; McGarity B; Sawhney R; Sinclair M; Thomas J; Valiozis I; Weltman M; Wilson M; Woodward A; Ahlenstiel G; Haque M; Levy M; Prewett E; Sievert W; Sood S; Tse E; Valaydon Z; Bowden S; Douglas M; New K; O'Keefe J; Hellard M; Doyle J; Stoove M; Thompson AJ, 2021, 'Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients with Difficult to Cure Characteristics', Clinical Infectious Diseases, vol. 73, pp. E3288 - E3295, http://dx.doi.org/10.1093/cid/ciaa1318

Dore G; Levy M, 2021, 'Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients with Difficult to Cure Characteristics', Clinical Infectious Diseases, http://dx.doi.org/10.1093/cid/ciaa1318

O'Brien ER; Whelan MC; Lama T; Levy M, 2021, 'Public health unit notifications of hepatitis C and their follow-up in South Western Sydney, Australia', Public Health Research and Practice, vol. 31, http://dx.doi.org/10.17061/PHRP30342010

Lubel JS; Roberts SK; Strasser SI; Thompson AJ; Philip J; Goodwin M; Clarke S; Crawford DHG; Levy MT; Shackel N, 2021, 'Australian recommendations for the management of hepatocellular carcinoma: a consensus statement', Medical Journal of Australia, vol. 214, pp. 475 - 483, http://dx.doi.org/10.5694/mja2.50885

Terrault NA; Cheung KW; Levy MT; Jourdain G, 2021, 'Reply to ‘Evidence against in utero transmission of hepatitis B virus’', Nature Reviews Gastroenterology and Hepatology, vol. 18, pp. 445 - 446, http://dx.doi.org/10.1038/s41575-021-00456-y

Lockart I; Hajarizadeh B; Alavi M; Davison S; Prakoso E; Levy MT; George J; Dore GJ; Danta M, 2021, 'Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival', Journal of Viral Hepatitis, vol. 28, pp. 710 - 718, http://dx.doi.org/10.1111/jvh.13475

Levy MT; Terrault NA, 2021, 'Caesarean section or non-breastfeeding for prevention of MTCT—beware of sending the wrong message', Journal of Viral Hepatitis, vol. 28, pp. 575 - 576, http://dx.doi.org/10.1111/jvh.13455

Terrault NA; Levy MT; Cheung KW; Jourdain G, 2021, 'Viral hepatitis and pregnancy', Nature Reviews Gastroenterology and Hepatology, vol. 18, pp. 117 - 130, http://dx.doi.org/10.1038/s41575-020-00361-w

Prince DS; Pipicella JL; Fraser M; Alvaro F; Maley M; Foo H; Middleton PMC; Davison SA; Dore GJ; McCaughan GW; Levy MT, 2021, 'Screening Emergency Admissions at Risk of Chronic Hepatitis C (SEARCH) to diagnose or ‘re-diagnose’ infections is effective in Australia', Journal of Viral Hepatitis, vol. 28, pp. 121 - 128, http://dx.doi.org/10.1111/jvh.13393

Razavi H; Blach S; Razavi-Shearer D; Abaalkhail F; Abbas Z; Abdallah A; Abrao Ferreira P; Abu Raddad LJ; Adda D; Agarwal K; Aghemo A; Ahmed A; Al-Busafi SA; Al-hamoudi W; Al-Kaabi S; Al-Romaihi H; Aljarallah B; AlNaamani K; Alqahtani S; Alswat K; Altraif I; Asselah T; Bacon B; Bessone F; Bizri AR; Block T; Bonino F; Brandão-Mello CE; Brown K; Bruggmann P; Brunetto MR; Buti M; Cabezas J; Calleja JL; Castro Batänjer E; Chan HLY; Chang H; Chen CJ; Christensen PB; Chuang WL; Cisneros L; Cohen C; Colombo M; Conway B; Cooper C; Craxi A; Crespo J; Croes E; Cryer D; Cupertino de Barros FP; Derbala M; Dillon J; Doss W; Dou X; Doyle J; Duberg AS; Dugan E; Dunn R; Dusheiko G; El Khayat H; El-Sayed MH; Eshraghian A; Esmat G; Esteban Mur R; Ezzat S; Falconer K; Fassio E; Ferrinho P; Flamm S; Flisiak R; Foster G; Fung J; García-Samaniego J; Gish RG; Gonçales F; Halota W; Hamoudi W; Hassany M; Hatzakis A; Hay S; Himatt S; Hoepelman IM; Hsu YC; Hui YT; Hunyady B; Jacobson I; Janjua N; Janssen H; Jarcuska P; Kabagambe K; Kanto T; Kao JH; Kaymakoglu S; Kershenobich D; Khamis F; Kim DJ; Kim DY; Kondili LA; Kottilil S; Kramvis A, 2021, 'The case for simplifying and using absolute targets for viral hepatitis elimination goals', Journal of Viral Hepatitis, vol. 28, pp. 12 - 19, http://dx.doi.org/10.1111/jvh.13412

Chan PPY; Levy MT; Shackel N; Davison SA; Prakoso E, 2020, 'Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia', Hepatobiliary and Pancreatic Diseases International, vol. 19, pp. 541 - 546, http://dx.doi.org/10.1016/j.hbpd.2020.06.013

Crane HG; Davison SA; Levy MT, 2020, 'Editorial: the emergence of non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI in patients with chronic hepatitis C', Alimentary Pharmacology and Therapeutics, vol. 51, pp. 168 - 169, http://dx.doi.org/10.1111/apt.15525

Hall S; Burns G; Levy M; Lubel J; Nicoll A; Matthews G; Desmond P; Sievert W; Bowden S; Locarnini S; Holmes J; Visvanathan K; Thompson A, 2020, 'A prospective study of nucleot(s)ide analogue discontinuation in non-cirrhotic HBeAg-negative chronic hepatitis B patients: interim analysis at week 48 demonstrates profound reductions of HBsAg associated with ALT flare', Journal of Hepatology, vol. 73, pp. S69 - S70, http://dx.doi.org/10.1016/s0168-8278(20)30674-7

Nicoll AJ; Roberts SK; Lim R; Mitchell J; Weltman M; George J; Wigg A; Stuart K; Gow P; MacQuillan G; Tse E; Levy M; Sood S; Zekry A; Cheng W; Mitchell J; Skoien R; Sievert W; Strasser SI; McCaughan GW, 2019, 'Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels', Alimentary Pharmacology and Therapeutics, vol. 49, pp. 1314 - 1322, http://dx.doi.org/10.1111/apt.15248

Mohsen W; Chan P; Whelan M; Glass A; Mouton M; Young E; Tran Q; Arora S; Davison S; Lama T; Cobrador C; Levy M, 2019, 'Hepatitis C treatment for difficult to access populations: can telementoring (as distinct from telemedicine) help?', Internal Medicine Journal, vol. 49, pp. 351 - 357, http://dx.doi.org/10.1111/imj.14072

Lockart I; Das A; Merrett N; Levy M, 2018, 'Migration route of Fasciola into the liver', JGH open, vol. 3, pp. 89 - 90, http://dx.doi.org/10.1002/jgh3.12101

Thilakanathan C; Wark G; Maley M; Davison S; Lawler J; Lee A; Shackel N; Nguyen V; Jackson K; Glass A; Locarnini SA; Levy MT, 2018, 'Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing', Liver International, vol. 38, pp. 1212 - 1219, http://dx.doi.org/10.1111/liv.13736

Levy MT; Mohsen W, 2018, 'Author reply', Internal Medicine Journal, vol. 48, pp. 486, http://dx.doi.org/10.1111/imj.13747

Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G, 2018, 'Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy', Clinical Gastroenterology and Hepatology, vol. 16, pp. 268 - 277, http://dx.doi.org/10.1016/j.cgh.2017.09.063

Ermerak GG; Behary J; Tran G; Koo K; Levy MT; Bassan MS, 2018, 'Mo1198 - Frailty and Aims65 Score Predict Mortality in Hospitalized Patients with Gastrointestinal Bleeding: A Prospective Cohort Study', Gastroenterology, vol. 154, http://dx.doi.org/10.1016/s0016-5085(18)32479-x

Nicoll A; Roberts SK; Lim R; Mitchell J; Weltman M; George J; Wigg A; Stuart K; Gow P; MacQuillan G; Tse E; Levy MT; Sood S; Zekry A; Cheng W; Mitchell J; Skoien R; Sievert W; Strasser S; McCaughan G, 2018, 'Mo1458 - Response to Mycphenolate Mofetil in Patents with Autoimmune Hepatitis who Fail Standard Therapy is Predicted by Serum Gammaglobulin Levels but not Cirrhosis', Gastroenterology, vol. 154, pp. S - 1213, http://dx.doi.org/10.1016/s0016-5085(18)34006-x

Wang XM; Holz LE; Chowdhury S; Cordoba SP; Evans KA; Gall MG; De Ribeiro AJV; Zheng YZ; Levy MT; Yu DMT; Yao TW; Polak N; Jolly CJ; Bertolino P; McCaughan GW; Gorrell MD, 2017, 'The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury', Immunology and Cell Biology, vol. 95, pp. 443 - 453, http://dx.doi.org/10.1038/icb.2016.116

Mohsen W; Levy MT, 2017, 'Hepatitis A to E: what's new?', Internal Medicine Journal, vol. 47, pp. 380 - 389, http://dx.doi.org/10.1111/imj.13386

Lubel J; Strasser S; Stuart KA; Dore G; Thompson A; Pianko S; Bollipo S; Mitchell JL; Fragomeli V; Jones T; Chivers S; Gow P; Iser D; Levy M; Tse E; Gazzola A; Cheng W; Nazareth S; Galhenage S; Wade A; Weltman M; Wigg A; MacQuillan G; Sasadeusz J; George J; Zekry A; Roberts SK, 2017, 'Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 – final results of the REV1TAL study', Antiviral Therapy, vol. 22, pp. 699 - 710, http://dx.doi.org/10.3851/IMP3168

Najjar Z; Gupta L; Pritchard-Jones J; Strasser SI; Levy MT; Liaw ST; Cowie BC, 2016, 'A survey of Sydney general practitioners' management of patients with chronic hepatitis B', The Medical journal of Australia, vol. 204, pp. 74.e1 - 74.e4, http://dx.doi.org/10.5694/mja15.00524

Visvanathan K; Dusheiko G; Giles M; Wong ML; Phung N; Walker S; Le S; Lim SG; Gane E; Ngu M; Hardikar W; Cowie B; Bowden S; Strasser S; Levy M; Sasaduesz J, 2016, 'Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: Position paper produced by Australian, UK and New Zealand key opinion leaders', Gut, vol. 65, pp. 340 - 350, http://dx.doi.org/10.1136/gutjnl-2015-310317

Greenup AJ; Tan PK; Nguyen V; Glass A; Davison S; Chatterjee U; Holdaway S; Samarasinghe D; Jackson K; Locarnini SA; Levy MT, 2015, 'Corrigendum to "efficacy and safety of tenofovir disoproxil fumarate (TDF) in pregnancy to prevent perinatal transmission of hepatitis B virus" (J Hepatol (2014) 61:502-507)', Journal of Hepatology, vol. 63, pp. 1054, http://dx.doi.org/10.1016/j.jhep.2015.07.017

Kemp W; Levy M; Weltman M; Lubel J, 2015, 'Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis', Journal of Gastroenterology and Hepatology (Australia), vol. 30, pp. 453 - 462, http://dx.doi.org/10.1111/jgh.12865

Holt SG; Gracey DM; Levy MT; Mudge DW; Irish AB; Walker RG; Baer R; Sevastos J; Abbas R; Boyd MA, 2014, 'A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection', AIDS Research and Therapy, vol. 11, http://dx.doi.org/10.1186/1742-6405-11-35

Ayres A; Yuen L; Jackson KM; Manoharan S; Glass A; Maley M; Yoo W; Hong SP; Kim SO; Luciani F; Bowden DS; Bayliss J; Levy MT; Locarnini SA, 2014, 'Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: Lack of potency and selection of resistance mutations', Journal of Viral Hepatitis, vol. 21, pp. 809 - 817, http://dx.doi.org/10.1111/jvh.12212

Nguyen V; Tan PK; Greenup AJ; Glass A; Davison S; Samarasinghe D; Holdaway S; Strasser SI; Chatterjee U; Jackson K; Locarnini SA; Levy MT, 2014, 'Anti-viral therapy for prevention of perinatal HBV transmission: Extending therapy beyond birth does not protect against post-partum flare', Alimentary Pharmacology and Therapeutics, vol. 39, pp. 1225 - 1234, http://dx.doi.org/10.1111/apt.12726

Roberts SK; Mitchell J; Leung R; Booth D; Bollipo S; Ostapowicz G; Sloss A; Mccaughan GW; Dore GJ; Thompson A; Crawford DH; Sievert W; Weltman M; Cheng W; George J; Angus P; Chu G; Cornwall M; Douglas M; Hallinan R; Haque M; Hawkin G; Jackson H; Johnson R; Kronborg I; Lee A; Leggett B; Mire ML; Levy M; Lubel J; MacQuillan G; Masson J; McDonald J; McGarity B; Mollison L; Nicoll A; Ombiga J; Riordan S; Roberts S; Strasser S; Thompson A; Watson J; Wenman J; Wigg A; Zekry A, 2014, 'Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies', Journal of Gastroenterology and Hepatology (Australia), vol. 29, pp. 179 - 184, http://dx.doi.org/10.1111/jgh.12424

Greenup AJ; Tan PK; Nguyen V; Glass A; Davison S; Chatterjee U; Holdaway S; Samarasinghe D; Jackson K; Locarnini SA; Levy MT, 2014, 'Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus', Journal of Hepatology, vol. 61, pp. 502 - 507, http://dx.doi.org/10.1016/j.jhep.2014.04.038

Nguyen V; Levy MT, 2014, 'Editorial: anti-viral therapy for prevention of perinatal HBV transmission - extending therapy beyond birth and the risk of post-partum flare; authors' reply', Alimentary Pharmacology & Therapeutics, vol. 40, pp. 116 - 116, http://dx.doi.org/10.1111/apt.12806

Tan PK; Chatterjee U; Glass A; Maley MW; Ayres A; Locarnini S; Levy M, 2012, 'Lamivudine in pregnancy: impact on hepatitis flares and HBeAg seroconversion post partum', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 27, pp. 181 - 181, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600367&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Greenup A-J; Chatterjee U; Smith LE; Levy M, 2012, 'The hepatitis B bear: novel patient orientated information enhances patient understanding of the phases of hepatitis B', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 27, pp. 166 - 166, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600340&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Levy MT, 2012, 'Preventing Perinatal Transmission of HBV: An Australian Perspective', Current Hepatitis Reports, vol. 11, pp. 206 - 212, http://dx.doi.org/10.1007/s11901-012-0144-4

Lawler J; Glass A; Chatterjee U; Wiseman E; Davison S; Manoharan S; Smith L; Yeo A; Ayres A; Locarnini S; Levy MT, 2011, 'Nucleot(s)ide analogues to prevent perinatal transmission of HBV: Lamivudine is effective but Tenofovir may be better', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 26, pp. 100 - 100, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295157300261&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Levy M; Glass A; Manoharan S; Paven G; Ng W; Wiseman E; Locarnini S; Ayres A, 2011, 'ANTIVIRAL-THERAPY IN PREGNANCY FOR PREVENTION OF HBV TRANSMISSION: SEVERE POST PARTUM HEPATIC FLARES ARE COMMON AND USUALLY SELF LIMITING', JOURNAL OF HEPATOLOGY, vol. 54, pp. S294 - S295, http://dx.doi.org/10.1016/S0168-8278(11)60735-6

Robotin MC; Kansil MQ; George J; Howard K; Tipper S; Levy M; Phung N; Penman AG, 2010, 'Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: Effects on health services utilisation', BMC Health Services Research, vol. 10, http://dx.doi.org/10.1186/1472-6963-10-215

Nguyen T; Thompson AJV; Bowden S; Croagh C; Bell S; Desmond PV; Levy M; Locarnini SA, 2010, 'Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia', Journal of Hepatology, vol. 52, pp. 508 - 513, http://dx.doi.org/10.1016/j.jhep.2010.01.007

Scott DR; Levy MT, 2010, 'Liver transient elastography (Fibroscan®): A place in the management algorithms of chronic viral hepatitis', Antiviral Therapy, vol. 15, pp. 1 - 11, http://dx.doi.org/10.3851/IMP1474

Scott D; Wong J; Spicer ST; Dent H; Mensah FK; McDonald S; Levy MT, 2010, 'Adverse Impact of Hepatitis C Virus Infection on Renal Replacement Therapy and Renal Transplant Patients in Australia and New Zealand', Transplantation, vol. 90, pp. 1165 - 1171, http://dx.doi.org/10.1097/TP.0b013e3181f92548

Nguyen T; Thompson AJ; Desmond PV; Bowden S; Levy MT; Locarnini S, 2009, 'Serum HBeAg and HBsAg titres: changing levels during the natural history of chronic hepatitis B', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 24, pp. A299 - A299, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Levy MT; Wiseman E, 2009, 'In reply', Medical Journal of Australia, vol. 191, pp. 357, http://dx.doi.org/10.5694/j.1326-5377.2009.tb02829.x

Levy MT; Wiseman E, 2009, 'Perinatal transmission of hepatitis B virus: an Australian experience REPLY', MEDICAL JOURNAL OF AUSTRALIA, vol. 191, pp. 357 - 357, http://dx.doi.org/10.5694/j.1326-5377.2009.tb02829.x

Robotin M; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy MT; Penman A, 2009, 'Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer', Journal of Hepatology, vol. 50, pp. 990 - 998, http://dx.doi.org/10.1016/j.jhep.2008.12.022


Back to profile page